Cardiff Oncology (CRDF) Total Liabilities (2011 - 2026)

Cardiff Oncology has reported Total Liabilities for 15 years, with the latest figure at $16.5 million in Q4 2025.

• Quarterly Total Liabilities rose 15.83% year-over-year to $16.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.5 million (up 15.83% YoY) and the FY2025 annual result came in at $16.5 million, up 15.83% from the prior year.
• Total Liabilities climbed to $16.5 million in Q4 2025 per CRDF's latest filing, from $15.0 million in the prior quarter.
• Over five years, Total Liabilities peaked at $17.1 million in Q2 2025 and troughed at $4.8 million in Q1 2021.
• A 5-year average of $11.4 million and a median of $10.8 million in 2022 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2021 and 2022: Total Liabilities fell 16.17% in 2021, then jumped 123.98% in 2022.
• Over 5 years, Total Liabilities stood at $9.1 million in 2021, then gained by 7.9% to $9.8 million in 2022, then grew by 20.82% to $11.9 million in 2023, then increased by 19.69% to $14.2 million in 2024, then rose by 15.83% to $16.5 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $16.5 million, $15.0 million, and $17.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.